Drug target insights

Keyphrases

Publications

volume 18, 2024

Nerges F Mistry
Tuberculosis research: Quo vadis. Drug target insights 18 (2024)
Nerges F Mistry
Tuberculosis research: Quo vadis. Drug target insights 18 (2024)
Sweety Parmar, Gemini Gajera, Nidhi Thakkar, Hanmanthrao S Palep, Vijay Kothari
Deciphering the molecular mechanisms underlying anti-pathogenic potential of a polyherbal formulation Enteropan® against multidrug-resistant Pseudomonas aeruginosa . Drug target insights 18 (2024)
Luka Diarra, Moussa Mariko, Salif Traore, Safi Bazi Dicko, Aboudou Dolo, Moussa Coulibaly, Daouda Sidibé, Moumouni Daou, Hachimi Poma, Madou Traore, Ibrahim Guindo
Evaluation of non-conformities in the drafting of bulletins for urine cytobacteriological examinations at Sikasso Hospital (Mali). Drug target insights 18 (2024)
Kavita Munjal, Yash Goel, Vinod Kumar Gauttam, Inderbir Padda, Madhav Singla, Smriti, Saurabh Gupta, Rohit Sharma
Molecular targets and therapeutic potential of baicalein: a review. Drug target insights 18 (2024)
Kavita Munjal, Yash Goel, Vinod Kumar Gauttam, Inderbir Padda, Madhav Singla, Smriti, Saurabh Gupta, Rohit Sharma
Molecular targets and therapeutic potential of baicalein: a review. Drug target insights 18 (2024)
Iyad Y Natsheh, Majd M Alsaleh, Ahmad K Alkhawaldeh, Duaa K Albadawi, Maisa' M Darwish, Mohammed Jamal A Shammout
The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields. Drug target insights 18 (2024)
Dablu Lal Gupta, Jhasketan Meher, Anjan Kumar Giri, Arvind K Shukla, Eli Mohapatra, Manisha M Ruikar, D N Rao
RBD mutations at the residues K417, E484, N501 reduced immunoreactivity with antisera from vaccinated and COVID-19 recovered patients. Drug target insights 18 (2024)
Abdur Rauf, Umer Rashid, Najla Al Masoud, Zuneera Akram, Anees Saeed, Naveed Muhammad, Taghrid S Alomar, Saima Naz, Marcello Iriti
In vivo analgesic, anti-inflammatory, sedative, muscle relaxant activities, and docking studies of 3',4',7,8-tetrahydroxy-3-methoxyflavone isolated from Pistacia chinensis . Drug target insights 18 (2024)
Luka Diarra, Moussa Mariko, Salif Traore, Safi Bazi Dicko, Aboudou Dolo, Moussa Coulibaly, Daouda Sidibé, Moumouni Daou, Hachimi Poma, Madou Traore, Ibrahim Guindo
Evaluation of non-conformities in the drafting of bulletins for urine cytobacteriological examinations at Sikasso Hospital (Mali). Drug target insights 18 (2024)
Nataliya Babyshkina, Nataliya Popova, Evgeny Grigoryev, Tatyana Dronova, Polina Gervas, Alexey Dobrodeev, Dmitry Kostromitskiy, Victor Goldberg, Sergey Afanasiev, Nadejda Cherdyntseva
Long-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report. Drug target insights 18 (2024)
Dablu Lal Gupta, Jhasketan Meher, Anjan Kumar Giri, Arvind K Shukla, Eli Mohapatra, Manisha M Ruikar, D N Rao
RBD mutations at the residues K417, E484, N501 reduced immunoreactivity with antisera from vaccinated and COVID-19 recovered patients. Drug target insights 18 (2024)
Nataliya Babyshkina, Nataliya Popova, Evgeny Grigoryev, Tatyana Dronova, Polina Gervas, Alexey Dobrodeev, Dmitry Kostromitskiy, Victor Goldberg, Sergey Afanasiev, Nadejda Cherdyntseva
Long-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report. Drug target insights 18 (2024)
Abdur Rauf, Umer Rashid, Najla Al Masoud, Zuneera Akram, Anees Saeed, Naveed Muhammad, Taghrid S Alomar, Saima Naz, Marcello Iriti
In vivo analgesic, anti-inflammatory, sedative, muscle relaxant activities, and docking studies of 3',4',7,8-tetrahydroxy-3-methoxyflavone isolated from Pistacia chinensis . Drug target insights 18 (2024)
Iyad Y Natsheh, Majd M Alsaleh, Ahmad K Alkhawaldeh, Duaa K Albadawi, Maisa' M Darwish, Mohammed Jamal A Shammout
The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields. Drug target insights 18 (2024)

volume 17, 2023

Ismin Zainol Abidin, Emma J Murphy, Gustavo Waltzer Fehrenbach, Emanuele Rezoagli, Noel Gately, Ian Major
A systematic review of mucoadhesive vaginal tablet testing. Drug target insights 17 (2023)
Supphachoke Khemla, Atibordee Meesing, Wantin Sribenjalux, Ploenchan Chetchotisakd
Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir. Drug target insights 17 (2023)
Vanessa Zambelli, Emma J Murphy, Paolo Delvecchio, Laura Rizzi, Roberto Fumagalli, Emanuele Rezoagli, Giacomo Bellani
Treatment with levosimendan in an experimental model of early ventilator-induced diaphragmatic dysfunction. Drug target insights 17 (2023)
Ria Pothoven
Management of urinary tract infections in the era of antimicrobial resistance. Drug target insights 17 (2023)
Marcello Iriti
Natural Products & Phytotherapeutics: why a new section? Drug target insights 17 (2023)
Bhavya Shetty, Ibrahim Fazal, Safiya Fatima Khan, Manjusha Nambiar, Khadijathul Irfana D, Rohit Prasad, Akshata Raj
Association between cardiovascular diseases and periodontal disease: more than what meets the eye. Drug target insights 17 (2023)
Alessandro Inno, Giuseppe Bogina, Giulio Settanni, Matteo Salgarello, Giovanni Foti, Carlo Pomari, Vincenzo Picece, Stefania Gori
First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression. Drug target insights 17 (2023)
Apichart So-Ngern, Naphol Osaithai, Atibordee Meesing, Worawat Chumpangern
Mortality rate and factors associated with mortality of carbapenem-resistant Enterobacteriaceae infection. Drug target insights 17 (2023)
Gemini Gajera, Niel Henriksen, Bryan Cox, Vijay Kothari
Identification of anti-pathogenic activity among in silico predicted small-molecule inhibitors of Pseudomonas aeruginosa LasR or nitric oxide reductase (NOR). Drug target insights 17 (2023)
Safiya Fatima Khan, Bhavya Shetty, Ibrahim Fazal, Asim Mustafa Khan, Faheem Muzaffar Mir, Muhamood Moothedath, V J Reshma, Muhaseena Muhamood
Licorice as a herbal extract in periodontal therapy. Drug target insights 17 (2023)
Gurvinder Singh Bumbrah, Sarika Jain, Zeeshan Fatima, Saif Hameed
Efficacy of LAMP assay for Mycobacterial spp. detection to prevent treatment delays and onset of drug resistance: a systematic review and meta-analysis. Drug target insights 17 (2023)
Bhavya Shetty, Ibrahim Fazal, Safiya Fatima Khan, Manjusha Nambiar, Khadijathul Irfana D, Rohit Prasad, Akshata Raj
Association between cardiovascular diseases and periodontal disease: more than what meets the eye. Drug target insights 17 (2023)
Marcello Iriti
Natural Products & Phytotherapeutics: why a new section? Drug target insights 17 (2023)
Ria Pothoven
Management of urinary tract infections in the era of antimicrobial resistance. Drug target insights 17 (2023)
Ratchanon Rattanathanoo, Jarin Chindaprasirt, Watchara Boonsawat, Panita Limpawattana, Sittichai Khamsai, Kittisak Sawanyawisuth
Are calcium channel blockers related to lung cancer? Drug target insights 17 (2023)
Ismin Zainol Abidin, Emma J Murphy, Gustavo Waltzer Fehrenbach, Emanuele Rezoagli, Noel Gately, Ian Major
A systematic review of mucoadhesive vaginal tablet testing. Drug target insights 17 (2023)
Alessandro Inno, Fabiana Marchetti, Matteo Valerio, Niccolò Giaj Levra, Filippo Alongi, Giovanni Foti, Stefania Gori
Activity of sotorasib against brain metastases from NSCLC harboring KRAS p.G12C mutation: a case report. Drug target insights 17 (2023)
Ebtehaj Saud Almughais, Fatmah Fahad Alreshidi, Hussain Gadelkarim Ahmed
Prevalence of antibiotic misuse in cases of pneumonia and diarrhea in Saudi Arabia. Drug target insights 17 (2023)
Feny J Ruparel, Siddhi K Shah, Jhanvi H Patel, Nidhi R Thakkar, Gemini N Gajera, Vijay O Kothari
Network analysis for identifying potential anti-virulence targets from whole transcriptome of Pseudomonas aeruginosa and Staphylococcus aureus exposed to certain anti-pathogenic polyherbal formulations. Drug target insights 17 (2023)

volume 16, 2022

Silvio Zuccarini, Fabrizio Puce, Alessandro Crisà
Anatomical and functional responses to single brolucizumab injection in neovascular age-related macular degeneration patients not responding to antiangiogenics: a case series. Drug target insights 16 (2022)
Monica Sharma, Kamini Walia, Nitin Bansal
Unmet needs for management of drug-resistant infections: low- and middle-income countries' viewpoint. Drug target insights 16 (2022)
Monica Sharma, Kamini Walia, Nitin Bansal
Unmet needs for management of drug-resistant infections: low- and middle-income countries' viewpoint. Drug target insights 16 (2022)
Thuy B Duong, Minh C Duong, James I Campbell, Hoang V M Nguyen, Hien H Nguyen, Hanh T B Bui, Chau V V Nguyen, Anita Heywood
MRSA carriage among healthcare workers in a Vietnamese intensive care unit: a prospective cohort study. Drug target insights 16 (2022)
Swinder Jeet Singh Kalra, Hari Shankar, Nasim Mansoori, Dablu Lal Gupta
Antibiotic-resistant bacteria originating from the gut may modulate the mucosal immune response during sepsis and septic shock. Drug target insights 16 (2022)
Sim Yi Xing, Lee Qiao Wei, Aisha Abushelaibi, Kok Song Lai, Swee Hua Erin Lim, Sathiya Maran
Current molecular approach for diagnosis of MRSA: a meta-narrative review. Drug target insights 16 (2022)
Sisir Nandi, Mohit Kumar, Rashmi Kumari, Aaruni Saxena
Exploring the inhibitory mechanisms of indazole compounds against SAH/MTAN-mediated quorum sensing utilizing QSAR and docking. Drug target insights 16 (2022)
Martino Carriero
Erythrodermic psoriasis and palmoplantar hyperkeratosis successfully treated with secukinumab: a case report. Drug target insights 16 (2022)
Sim Yi Xing, Lee Qiao Wei, Aisha Abushelaibi, Kok Song Lai, Swee Hua Erin Lim, Sathiya Maran
Current molecular approach for diagnosis of MRSA: a meta-narrative review. Drug target insights 16 (2022)
Pariwat Phungoen, Jessada Sarunyaparit, Korakot Apiratwarakul, Lumyai Wonglakorn, Atibordee Meesing, Kittisak Sawanyawisuth
The association of ESBL Escherichia coli with mortality in patients with Escherichia coli bacteremia at the emergency department. Drug target insights 16 (2022)
Ramendra Pati Pandey, Riya Mukherjee, Chung-Ming Chang
Antimicrobial resistance surveillance system mapping in different countries. Drug target insights 16 (2022)
Syed Fahim Shah, Sohail Aziz Paracha, Waheed Ullah, Iqbal Muhammad, Somaid Iqbal, Aisha Gul, Mudassir Hussain, Hafiz Ullah, Sadir Zaman
Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district. Drug target insights 16 (2022)
Syed Fahim Shah, Sohail Aziz Paracha, Waheed Ullah, Iqbal Muhammad, Somaid Iqbal, Aisha Gul, Mudassir Hussain, Hafiz Ullah, Sadir Zaman
Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district. Drug target insights 16 (2022)
Sisir Nandi, Mohit Kumar, Rashmi Kumari, Aaruni Saxena
Exploring the inhibitory mechanisms of indazole compounds against SAH/MTAN-mediated quorum sensing utilizing QSAR and docking. Drug target insights 16 (2022)
Vijay Kothari
AMR research: a perspective from personal experience. Drug target insights 16 (2022)
Vijay Kothari
AMR research: a perspective from personal experience. Drug target insights 16 (2022)